 Herbert Nagamoto
Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 13 | 2024 | 1642 | 0.800 |
Why?
| | Mental Health Services | 9 | 2024 | 475 | 0.720 |
Why?
| | Suicide, Attempted | 3 | 2015 | 426 | 0.610 |
Why?
| | Brain Injuries | 4 | 2015 | 507 | 0.470 |
Why?
| | United States Department of Veterans Affairs | 6 | 2024 | 779 | 0.430 |
Why?
| | Psychiatry | 2 | 2012 | 195 | 0.340 |
Why?
| | Telemedicine | 4 | 2017 | 967 | 0.340 |
Why?
| | Executive Function | 2 | 2015 | 470 | 0.340 |
Why?
| | Suicidal Ideation | 3 | 2016 | 584 | 0.320 |
Why?
| | Health Services Accessibility | 3 | 2024 | 1101 | 0.300 |
Why?
| | Self-Injurious Behavior | 1 | 2011 | 141 | 0.290 |
Why?
| | Terminology as Topic | 1 | 2011 | 259 | 0.290 |
Why?
| | Suicide | 2 | 2016 | 729 | 0.260 |
Why?
| | Indians, North American | 4 | 2017 | 598 | 0.220 |
Why?
| | Primary Health Care | 3 | 2024 | 1737 | 0.220 |
Why?
| | Mental Disorders | 5 | 2024 | 1171 | 0.210 |
Why?
| | Antipsychotic Agents | 3 | 2015 | 211 | 0.190 |
Why?
| | Videoconferencing | 3 | 2015 | 65 | 0.180 |
Why?
| | Rural Population | 4 | 2017 | 661 | 0.170 |
Why?
| | Internship and Residency | 1 | 2011 | 1269 | 0.160 |
Why?
| | Schizophrenia | 3 | 2009 | 464 | 0.130 |
Why?
| | Psychometrics | 2 | 2012 | 732 | 0.130 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2017 | 890 | 0.120 |
Why?
| | Hospitals, Veterans | 3 | 2014 | 258 | 0.120 |
Why?
| | Culturally Competent Care | 1 | 2017 | 72 | 0.120 |
Why?
| | Value of Life | 1 | 2016 | 19 | 0.120 |
Why?
| | Attitude to Death | 1 | 2016 | 76 | 0.110 |
Why?
| | Movement Disorders | 1 | 2015 | 69 | 0.110 |
Why?
| | United States | 10 | 2024 | 16126 | 0.110 |
Why?
| | Evoked Potentials, Auditory | 2 | 2005 | 181 | 0.100 |
Why?
| | Outpatients | 2 | 2015 | 447 | 0.100 |
Why?
| | United States Indian Health Service | 1 | 2013 | 45 | 0.090 |
Why?
| | Disability Evaluation | 1 | 2014 | 311 | 0.090 |
Why?
| | Statistics as Topic | 1 | 2012 | 283 | 0.090 |
Why?
| | Psychiatric Department, Hospital | 1 | 2011 | 12 | 0.090 |
Why?
| | Neuropsychological Tests | 2 | 2015 | 1137 | 0.080 |
Why?
| | Personality Assessment | 1 | 2011 | 79 | 0.080 |
Why?
| | Aggression | 1 | 2012 | 180 | 0.080 |
Why?
| | Inservice Training | 1 | 2011 | 118 | 0.080 |
Why?
| | Health Plan Implementation | 1 | 2011 | 141 | 0.080 |
Why?
| | Rural Health Services | 1 | 2011 | 138 | 0.080 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 201 | 0.080 |
Why?
| | Inpatients | 1 | 2014 | 553 | 0.070 |
Why?
| | Humans | 19 | 2024 | 145783 | 0.070 |
Why?
| | Hallucinations | 1 | 2009 | 32 | 0.070 |
Why?
| | Family Therapy | 1 | 2009 | 67 | 0.070 |
Why?
| | Cooperative Behavior | 1 | 2011 | 463 | 0.070 |
Why?
| | Population Surveillance | 1 | 2011 | 484 | 0.070 |
Why?
| | Middle Aged | 8 | 2024 | 36309 | 0.060 |
Why?
| | Adult | 10 | 2024 | 40881 | 0.060 |
Why?
| | Risk Assessment | 2 | 2016 | 3752 | 0.060 |
Why?
| | Pilot Projects | 1 | 2012 | 1898 | 0.060 |
Why?
| | Decision Support Techniques | 1 | 2011 | 480 | 0.060 |
Why?
| | Ondansetron | 1 | 2005 | 20 | 0.050 |
Why?
| | Serotonin Antagonists | 1 | 2005 | 32 | 0.050 |
Why?
| | Male | 12 | 2024 | 73011 | 0.050 |
Why?
| | Program Evaluation | 2 | 2024 | 944 | 0.050 |
Why?
| | Military Personnel | 1 | 2012 | 739 | 0.050 |
Why?
| | Reflex, Startle | 1 | 2004 | 75 | 0.050 |
Why?
| | Mass Screening | 1 | 2013 | 1361 | 0.050 |
Why?
| | Female | 11 | 2024 | 79045 | 0.050 |
Why?
| | Hospitalization | 1 | 2014 | 2461 | 0.050 |
Why?
| | Algorithms | 1 | 2011 | 1851 | 0.050 |
Why?
| | Health Services Needs and Demand | 2 | 2017 | 280 | 0.050 |
Why?
| | Quality Improvement | 1 | 2011 | 1296 | 0.040 |
Why?
| | Colorado | 1 | 2011 | 4556 | 0.040 |
Why?
| | Aged | 4 | 2015 | 26217 | 0.040 |
Why?
| | Databases, Factual | 2 | 2013 | 1491 | 0.030 |
Why?
| | Alaska Natives | 1 | 2017 | 97 | 0.030 |
Why?
| | Veterans Health | 1 | 2017 | 190 | 0.030 |
Why?
| | Psychological Tests | 1 | 2016 | 130 | 0.030 |
Why?
| | Mental Health | 1 | 2021 | 796 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2017 | 560 | 0.030 |
Why?
| | Acoustic Stimulation | 2 | 2005 | 333 | 0.020 |
Why?
| | Research | 1 | 2015 | 431 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2012 | 330 | 0.020 |
Why?
| | Iraq War, 2003-2011 | 1 | 2012 | 171 | 0.020 |
Why?
| | Self Report | 1 | 2016 | 876 | 0.020 |
Why?
| | Afghan Campaign 2001- | 1 | 2012 | 193 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 2123 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1327 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1001 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2110 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 2000 | 0.020 |
Why?
| | Decision Making | 1 | 2015 | 982 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 4330 | 0.020 |
Why?
| | Young Adult | 2 | 2015 | 14254 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 2875 | 0.010 |
Why?
| | Quetiapine Fumarate | 1 | 2004 | 26 | 0.010 |
Why?
| | Clozapine | 1 | 2004 | 20 | 0.010 |
Why?
| | Dibenzothiazepines | 1 | 2004 | 18 | 0.010 |
Why?
| | Risperidone | 1 | 2004 | 30 | 0.010 |
Why?
| | Placebos | 1 | 2005 | 193 | 0.010 |
Why?
| | Medication Adherence | 1 | 2009 | 540 | 0.010 |
Why?
| | Cohort Studies | 1 | 2015 | 6033 | 0.010 |
Why?
| | Patient Satisfaction | 1 | 2009 | 712 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5428 | 0.010 |
Why?
| | Auditory Perception | 1 | 2004 | 115 | 0.010 |
Why?
| | Health Status | 1 | 2009 | 835 | 0.010 |
Why?
| | Benzodiazepines | 1 | 2004 | 168 | 0.010 |
Why?
| | Reaction Time | 1 | 2004 | 434 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2004 | 533 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 2005 | 610 | 0.010 |
Why?
| | Receptors, Nicotinic | 1 | 2005 | 327 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1043 | 0.010 |
Why?
| | Treatment Outcome | 2 | 2009 | 11794 | 0.010 |
Why?
| | Risk Factors | 1 | 2016 | 10919 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 8347 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2005 | 2064 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 6085 | 0.010 |
Why?
| | Quality of Life | 1 | 2009 | 3211 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 22577 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 17330 | 0.010 |
Why?
|
|
Nagamoto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|